Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- Kahn Swick & Foti, LLCAvis Budget Group, Inc. Notice of September 29, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application DeadlineKahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Avis Budget Group, Inc. ("Avis" or the "Company") (NASDAQ: CAR) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of investors who purchased or otherwise acquired Avis securities (including those who bought Avis common stock to cover a...
- ChargePoint Holdings, Inc.ChargePoint to Announce Second Quarter Fiscal Year 2027 Financial Results on September 2, 2026CAMPBELL, Calif., August 19, 2026--ChargePoint Holdings, Inc. (NYSE: CHPT) ("ChargePoint" or the "Company"), a leading provider of EV charging solutions, today announced it will release financial results for the second quarter of fiscal year 2027, which ended July 31, 2026, on September 2, 2026. ChargePoint will host a conference call to review the Company’s financial results at 1:30 p.m.
- GRWDrive Wise Innovations Launches 37 New EV Chargers Across FloridaDrive Wise Innovations has completed the rollout of 37 new electric vehicle chargers across Florida, adding more charging options for drivers and expanding the company's presence in the state's growing EV market.To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8111/309886_c7a3ad9f64bfbb15_001full.jpgThe new chargers are now installed and operational. The project was carried out after...
- GraebelGraebel and NBCUniversal Recognized with Silver Brandon Hall Group™ Award for Excellence in Talent ManagementThe award recognizes the companies for measured success in technology implementation and builds on a previous Brandon Hall Group™ award honoring innovation in talent mobility — NBCUniversal (NBCU), in partnership with longtime global mobility partner...
- JEDEC® Announces Automotive Electronics Forum in September 2026ARLINGTON, Va., August 19, 2026--JEDEC Solid State Technology Association, the global leader in the development of standards for the microelectronics industry, today announced that it is hosting an Automotive Electronics Forum on September 17, 2026 in Santa Clara, CA. Advance registration is required and space is limited. For more information and registration, visit the JEDEC website.
- ToyotaMeet the Drivers Behind the Helmets in TOYOTA RACING’s PIT STOP TONIGHTCompanies: ToyotaWhat happens when you combine the split-second intensity of a NASCAR® pit stop with the quick wit of one of YouTube’s most recognizable creators? You get PIT STOP TONIGHT – TOYOTA RACING’s new four-episode YouTube series that trades traditional driver interviews for fast-paced entertainment designed […] The post Meet the Drivers Behind the Helmets in <em>TOYOTA RACING’s PIT STOP TONIGHT</em> appeared first on Toyota USA Newsroom.
- Hengrui Pharma Reports 2026 Interim Results as Innovation and Globalization Continue to Drive Business MomentumHengrui Pharma (“Hengrui” or “the Company”) today announced its financial results for the first half of 2026. During the reporting period, innovative drugs remained the Company’s key growth driver, while globalization initiatives continued to validate the global value of Hengrui’s innovation portfolio. Financial Highlights In the first half of 2026, Hengrui reported revenue of RMB15.46 billion. Drug sales revenue was RMB13.95 billion, representing a year-over-year increase of 1.87%. Innovative drug sales increased by 16.38% year-over-year and accounted for 63.16% of total drug sales, with non-oncology innovative drug sales increasing by 73.97% year-over-year and emerging as an increasingly important growth driver. Net profit attributable to shareholders of the listed company was RMB4.47 billion, up 0.34%. R&D investment totaled RMB4.61 billion, representing 29.8% of revenue. Pipeline and Regulatory Highlights Hengrui continued to advance its pipeline in China during the reporting period, obtaining seven innovation-related approvals, including two Class 1 innovative medicines, one Class 2 innovative medicine and four additional indications. At the end of the reporting period, nine marketing applications had been accepted for review by China’s National Medical Products Administration, while 17 clinical programs had advanced to Phase III, 22 to Phase II, and 10 innovative assets had entered Phase I clinical development. Hengrui also reported progress across its metabolic pipeline. Two Phase III studies of ribupatide injection, a GLP-1/GIP dual receptor agonist, in China for type 2 diabetes reported positive topline results, supporting a planned NDA submission. HRS-7535, an oral small molecule GLP-1 receptor agonist, met all primary and key secondary endpoints at Week 44 in a China Phase III obesity study, with continued weight loss through Week 50 and mean body-weight reduction of up to 11.1%. An NDA submission is planned. Global Partnerships and Business Development Hengrui continued to advance its globalization strategy through diversified collaboration models. Since 2023, the Company has completed 13 overseas business development transactions, including out-licensing, NewCo and strategic alliances, with a total potential transaction value of approximately US$42 billion. These collaborations include leading global pharmaceutical companies such as BMS, GSK and others. Among the diversified collaboration models Hengrui has explored, NewCo has also seen important progress in 2026. Kailera Therapeutics completed its Nasdaq IPO in April 2026, becoming one of the largest biotech IPOs at the time. Braveheart Bio also successfully listed on the Nasdaq Global Market on August 6, 2026. Scientific Recognition During the reporting period, 204 research findings related to Hengrui products were published in academic journals and received international recognition. Hengrui participated in the American Society of Clinical Oncology Annual Meeting for the 16th consecutive year, with 91 studies accepted, including 11 oral presentations—a new high for the Company. Research in non-oncology areas was also presented at major international congresses, including the American Diabetes Association, International Stroke Conference, World Congress of Nephrology, American College of Cardiology, American Academy of Dermatology, and European Alliance of Associations for Rheumatology. Outlook Looking ahead, Hengrui will continue to advance its innovation and globalization strategy, while further pursuing its dual-growth strategy across oncology and chronic diseases. The Company will strengthen its global R&D capabilities, pursue diversified international collaboration models, and continue to focus on delivering sustainable long-term value and bringing more high-quality innovative therapies to patients worldwide.
- YFOREYFORE Unveils New North America Headquarters and Facility in AtlantaThe August 26 grand opening brings local R&D, advanced manufacturing, and supply chain capabilities directly to regional OEM partners. — YFORE, a global Tier 1 automotive electronics supplier specializing in intelligent mobility, will celebrate the...
- Take 5 Oil Change Opens First Location in Salem, ORNew shop offers a fast, stay-in-your-car oil change for local drivers
- Kerrigan Advisors Represents Car Pros Automotive Group in Sale of Kia Dealership in Huntington Beach to Sutherlin Automotive GroupCompanies: KiaINCLINE VILLAGE, Nev., August 19, 2026--Kerrigan Advisors, the leading exclusive sell-side advisor and thought partner to auto dealers nationwide, represented Car Pros Automotive Group, a leading Southern California dealership group, in the sale of Car Pros Kia Huntington Beach to Sutherlin Automotive Group, which recently acquired the Subaru and Volkswagen franchises in the market and also owns dealerships in Tennessee and Alabama. Car Pros Kia Huntington Beach ranked as the #1 Kia dealer in Or
- ChargePointChargePoint and Portland International Airport Set New Standard for Rental Car Electrification with Industry-Leading Overhead Fast ChargingCAMPBELL, Calif., August 19, 2026--ChargePoint (NYSE: CHPT), a global leader in electric vehicle (EV) charging solutions, today announced a rapid EV charging deployment at Portland International Airport (PDX) - one that redefines how airports approach rental car electrification. The installation features an overhead charging system with retractable cable management that eliminates the traditional trade-offs between space, cost, and equipment durability, delivering a blueprint for airports worldw
- SOUEAST Rides MENA’s Electrification Wave with Its Hybrid PortfolioDriven by evolving government policies, expanding charging infrastructure, and consumer incentives, the new energy vehicle (NEV) market in the Middle East and North Africa (MENA) region has grown rapidly, unlocking new opportunities for global automotive brands. Building on its hybrid technology expertise, SOUEAST is strengthening its presence in this dynamic market and accelerating its global expansion strategy.